GDNF and Parkinson disease: A publication claimed that the treatment with HIRMAb-GDNF caused proliferative lesions in the pancreas of four of seven animals at the low dose of 1 mg/kg but not at the high dose of 5 mg/kg in an MPTP-PD model in the rhesus monkey [126].